Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?

Author： Kumar V.  

Publisher： Springer Publishing Company

ISSN： 1573-9538

Source： Purinergic Signalling, Vol.9, Iss.2, 2013-06, pp. : 145-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular endothelial growth factor receptors and the therapeutic targeting of angiogenesis in cancer: where do we go from here?

By Bruce1 David   Tan Peng H.  

Cell Communication and Adhesion, Vol. 18, Iss. 5, 2011-10 ,pp. : 85-103

Informa Healthcare

Access to resources Recommend Favorite

Where will all the PhDs go?

By Graham M.H.  

Trends in Ecology and Evolution, Vol. 14, Iss. 5, 1999-05 ,pp. : 208-208

Elsevier

Access to resources Recommend Favorite

Evolving dispersal: where to go next?

By Ferriere R.R.   Belthoff J.R.J.R.   Olivieri I.I.   Krackow S.S.  

Trends in Ecology and Evolution, Vol. 15, Iss. 1, 2000-01 ,pp. : 5-7

Elsevier

Access to resources Recommend Favorite

Anticipation in Lynch Syndrome: Where We Are Where We Go

By  

Current Genomics, Vol. 12, Iss. 7, 2011-11 ,pp. : 451-465

Bentham Science Publishers

Access to resources Recommend Favorite

The Pathogenesis of Lung Cancer and Chromosome 11

By  

Current Genomics, Vol. 1, Iss. 3, 2000-11 ,pp. : 281-288

Bentham Science Publishers

Access to resources Recommend Favorite